Expression of epidermal growth factor, tumor necrosis factor-alpha, and interleukin-1alpha in chronic otitis media with or without cholesteatoma.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Otology and Neurotology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 12218613
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhanced epithelial proliferation due to elevated levels of interleukin-1 receptors in middle ear cholesteatomas

  2007cited by this paper
• Interleukin 1 (IL-1) and IL-1-receptor antagonist (IL-1-RA) in middle ear cholesteatoma: an analysis of protein production and biological activity

  2004cited by this paper
• Cytokines and adhesion molecules in middle ear cholesteatoma. A role in epithelial growth?

  1999cited by this paper
• Different production of interleukin-1alpha, interleukin-1beta and interleukin-8 from cholesteatomatous and normal epithelium.

  1998cited by this paper
• A Study on Epidermal Proliferation Ability in Cholesteatoma

  1998cited by this paper
• Interleukin-1 alpha, interleukin-1 beta and interleukin-8 gene expression in human aural cholesteatomas.

  1996cited by this paper
• Clinical and biochemical studies of bone destruction in cholesteatoma

  1996cited by this paper
• Localization of Cytokines in Cholesteatoma Tissue

  1995cited by this paper
• Expression and localization of mRNA for epidermal growth factor and epidermal growth factor receptor in human cholesteatoma.

  1994cited by this paper
• Cytokines and growth factors in the regulation of bone remodeling

  1993cited by this paper
• Aberrant expression of epidermal growth factor receptor in aural cholesteatoma

  1993cited by this paper
• Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear.

  1992cited by this paper
• The role of tumor necrosis factor-alpha in bone resorption of cholesteatoma.

  1991cited by this paper
• Tumor Necrosis Factor Alpha in Middle Ear Cholesteatoma and its Effect on Keratinocytes in Vitro

  1991cited by this paper
• Immunologically activated cells in aural cholesteatoma.

  1991cited by this paper
• Bone Destruction Mechanisms in Chronic Otitis Media with Cholesteatoma: Specific Production by Cholesteatoma Tissue in Culture of Bone-Resorbing Activity Attributable to Interleukin-1 Alpha

  1991cited by this paper
• Third place--Resident Basic Science Award 1990. Interleukin 1 causing bone destruction in middle ear cholesteatoma.

  1990cited by this paper
• Localization of interleukin-1 in human cholesteatoma.

  1990cited by this paper
• The Interleukins

  1988cited by this paper
• Bone resorption in cholesteatoma: Epithelial‐mesenchymal cell interaction and collagenase production

  1987cited by this paper
• Tumor necrosis factor and interleukin-1: role in acute inflammation and microvascular injury.

  1987cited by this paper
• Epidermal growth factor, its receptor, and related proteins.

  1986cited by this paper
• Bone Erosion in Experimental Cholesteatoma — The Effects of Implanted Barriers

  1985cited by this paper
• Pressure-Induced Bone Resorption in the Middle Ear

  1985cited by this paper
• Pathogenic factors in bone resorption in cholesteatoma.

  1984cited by this paper
• Interleukin 1 stimulation of collagenase production by cultured fibroblasts

  1983cited by this paper
• ULTRASTRUCTURAL EVALUATION OF BIOCHEMICAL EVENTS OF BONE RESORPTION IN HUMAN CHRONIC OTITIS MEDIA

  1982cited by this paper
• Bone resorption in chronic otitis media. The role of cholesteatoma, a must or an adjunct?

  1981cited by this paper
• The aetiology of bone destruction in chronic otitis media

  1974cited by this paper

• Comparison of Tissue Factors in the Ontogenetic Aspects of Human Cholesteatoma

  2024cites this paper
• The Science of Cholesteatoma.

  2024cites this paper
• Micro RNAs and Circular RNAs in Different Forms of Otitis Media

  2023cites this paper
• Morphopathogenesis of Adult Acquired Cholesteatoma

  2023cites this paper
• A Role for Mast Cell-Mediated Antibodies in the Formation of Cholesteatoma and Cholesteatoma-Induced Bone Erosion

  2023cites this paper
• Review of potential medical treatments for middle ear cholesteatoma

  2022cites this paper
• Investigation of EGF, IL1-α and IL-6 levels and selected hematological parameters (NLR, MPV) in patients with the chronic cholesteatomatous otitis media.

  2022influential citation
• Expression of tumor necrosis factor Alpha, interleukin-1 and matrix metalloproteinase-9 and pathomorphological changes in acquired middle ear cholesteatoma

  2021cites this paper
• Complex Evaluation of Tissue Factors in Pediatric Cholesteatoma

  2021cites this paper
• The Medially-Invasive Cholesteatoma: An Aggressive Subtype of a Common Pathology

  2020cites this paper
• FACTOR-ALPHA AND INTERLEUKIN-1 RECEPTORS IN MIDDLE EAR HOLESTEATOMA EKSPRESIJA RECEPTORA FAKTORA NEKROZE TUMORA ALFA I INTERLEUKINA-1 KOD HOLESTEATOMA SREDNJEG UHA

  2020cites this paper
• Chronic inflammation of middle ear cholesteatoma promotes its recurrence via a paracrine mechanism

  2020influential citation
• Relationship between clinicopathological characteristics and CYLD expression in patients with cholesteatoma

  2020cites this paper
• Serum sclerostın levels ın chronıc otıtıs medıa wıth and wıthout cholesteatoma.

  2020cites this paper
• SEM BSE 3D Image Analysis of Human Incus Bone Affected by Cholesteatoma Ascribes to Osteoclasts the Bone Erosion and VpSEM dEDX Analysis Reveals New Bone Formation

  2020cites this paper
• Bondy Procedure: Our Experience

  2019cites this paper
• Cholesteatoma-associated W broblasts modulate epithelial growth and di V erentiation through KGF / FGF 7 secretion

  2019cites this paper
• Spontaneous Resolution of Cholesteatoma in a Patient on Long-Term Infliximab

  2019cites this paper
• Osteoclasts Modulate Bone Erosion in Cholesteatoma via RANKL Signaling

  2019cites this paper
• Scanning Electron Microscopy in the Evaluation of Defects to the Ossicular Chain in the Course of Chronic Otitis Media

  2019cites this paper
• Comparative immunohistochemical study of acquired cholesteatoma in children and adults

  2018cites this paper
• Cytokeratin 13, Cytokeratin 17, and Ki-67 Expression in Human Acquired Cholesteatoma and Their Correlation With Its Destructive Capacity

  2017cites this paper
• Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives

  2016influential citation
• Diagnostics

  2016cites this paper
• Mean Platelet Volume as a Potential Predictor of Cholesteatoma in Children

  2016cites this paper
• The 100 Most Cited Turkish Papers in the Otorhinolaryngology Journals of Web of Science

  2016cites this paper
• Influence of Ossicular Chain Damage on Hearing After Chronic Otitis Media and Cholesteatoma Surgery: A Systematic Review and Meta-analysis.

  2015cites this paper
• Updates and Knowledge Gaps in Cholesteatoma Research

  2015cites this paper
• Increased Acquired Cholesteatoma Risk in Patients with Osteoporosis: A Retrospective Cohort Study

  2015cites this paper
• The role of Tumor Necrosis Factor -Alpha (TNF-α) in bone resorption present in middle ear cholesteatoma

  2015cites this paper
• Etiopathogenesis of acquired cholesteatoma: Prominent theories and recent advances in biomolecular research

  2015cites this paper
• Increased permeability of the epithelium of middle ear cholesteatoma

  2015cites this paper
• The 100 Most Cited Turkish Papers in the Otorhinolaryngology Journals of Web of Science.

  2015cites this paper
• Evaluation of bcl-2, bax and c-erbB-2 Levels in Chronic Otitis Patients with or without Cholesteatoma.

  2015cites this paper
• Possible participation of acidic pH in bone resorption in middle ear cholesteatoma

  2014cites this paper
• Jak-Stat signaling pathway may play a role in the pathogenesis of cholesteatoma.

  2014cites this paper
• Activation of the EGFR/Akt/NF-κB/cyclinD1 survival signaling pathway in human cholesteatoma epithelium

  2014cites this paper
• Inflammatory stress and sarcomagenesis: a vicious interplay

  2013cites this paper
• The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence.

  2013cites this paper
• Expression of disintegrin and metalloproteinase family proteins 10, 12 and 17 in cholesteatoma.

  2013cites this paper
• Expression of Tumor Necrosis Factor-Like Weak Inducer of Apoptosis in Human Middle Ear Cholesteatoma

  2013cites this paper
• Cholesteatoma Fibroblasts Promote Epithelial Cell Proliferation through Overexpression of Epiregulin

  2013cites this paper
• [Keratinocyte growth factor and its receptor in middle-ear cholesteatoma].

  2013cites this paper
• The Role of EGFR/PI3K/Akt/cyclinD1 Signaling Pathway in Acquired Middle Ear Cholesteatoma

  2013cites this paper
• Cholesteatoma-associated fibroblasts modulate epithelial growth and differentiation through KGF/FGF7 secretion

  2012cites this paper
• Interleukin‐8 production in response to tumor necrosis factor‐alpha by cholesteatoma keratinocytes in cell culture

  2011cites this paper
• Early Loading After Single-Stage Bone-Anchored Implantation in Adults

  2011cites this paper
• Expression of Tumor Necrosis Factor-α, Interleukin-1α, Interleukin-6 and Interleukin-10 in Chronic Otitis Media with Bone Osteolysis

  2011cites this paper
• Expression of IL-17 and Its Role in Bone Destruction in Human Middle Ear Cholesteatoma

  2010cites this paper
• Expression of Keratinocyte Growth Factor and Its Receptor in Noncholesteatomatous and Cholesteatomatous Chronic Otitis Media

  2010cites this paper
• [Molecular control of bone resorption in chronic otitis media with cholesteatoma].

  2010cites this paper
• Bilateral promontory fistula due to noncholesteatomatous chronic otitis media

  2009cites this paper
• The Role of Inflammatory Mediators in the Pathogenesis of Otitis Media and Sequelae

  2008cites this paper
• [Challenge prevention. From curative to preventive medicine-strategic and operational challenges].

  2008cites this paper
• Catabolism of Glycoconjugates in Chronic Otitis Media with Cholesteatoma

  2007cites this paper
• Comparative analysis of the epithelium stroma interaction of acquired middle ear cholesteatoma in children and adults

  2007cites this paper
• Evaluation of c-MYC Status in Primary Acquired Cholesteatoma by Using Fluorescence In Situ Hybridization Technique

  2006cites this paper
• Identification of specific gene expression profiles in fibroblasts derived from middle ear cholesteatoma.

  2006cites this paper
• The pathophysiology of cholesteatoma.

  2006cites this paper
• The role of Tumor Necrosis Factor-Alpha ( TNF-α ) in bone resorption present in middle ear cholesteatoma Summary

  2006influential citation
• The role of cytokines in acquired middle ear cholesteatoma : literature review Summary

  2005cites this paper
• Pseudomonas aeruginosa Lipopolysaccharide Induction of Keratinocyte Proliferation, NF-κB, and Cyclin D1 Is Inhibited by Indomethacin1

  2005cites this paper
• Recent advances in otitis media. 4A. Molecular biology.

  2005cites this paper
• The role of cytokines in acquired middle ear cholesteatoma: literature review

  2004cites this paper
• Immunohistochemistry and histopathological assessment of the cholesteatoma of the ear.

  2004cites this paper
• Epidermal Growth Factor Expression in Middle Ear Cholesteatoma

  2004cites this paper
• Fibroblast growth factor receptor expression in aural polyps: predictor of cholesteatoma?

  2004cites this paper
• [Cell adhesion proteins in external auditory canal cholesteatoma].

  2004cites this paper
• Lipopolysaccharide Concentration and Bone Resorption in Cholesteatoma

  2003cites this paper